Furthermore, it was shown that broad inhibition of enolase had minimal toxicity in ENO1-intact glioma cells and normal human astrocytes while being lethal to the ENO-1 deficient cells, an appropriate setting for employing a ‘synthetic lethal’ strategy. Here, ENO1 is linked to glioma.